Navigation Links
InspireMD to Ring Opening Bell at New York Stock Exchange on Thursday, October 24th
Date:10/23/2013

BOSTON, Oct. 23, 2013 /PRNewswire/ -- InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection stents, announced today that it will ring the Opening Bell at the New York Stock Exchange on Thursday, October 24, 2013 at 9:30 a.m. ET.

Representing the Company, Alan Milinazzo, Chief Executive Officer, and Craig Shore, Chief Financial Officer, will be joined by members of the InspireMD management team to ring the Opening Bell.

"We look forward to ringing the Opening Bell at the New York Stock Exchange as we celebrate the progress made by the Company over the past year," said Alan Milinazzo, Chief Executive Officer of InspireMD.  "Over the next year, we are looking forward to several exciting milestones within our clinical and product development programs, as well as for our commercialization operations.  This includes the announcement next week of 12-month follow-up data for the MASTER trial in San Francisco at the Transcatheter Cardiovascular Therapeutics (TCT) Conference on October 29th."

A live webcast of the NYSE Opening Bell Ceremony will be available online at:
https://nyse.nyx.com/the-bell/todays-bells-live.

A replay of the NYSE Opening Bell Ceremony and photos from the event will be available at:
www.Inspire-MD.com or https://exchanges.nyx.com/new-york-stock-exchange-0.

About InspireMD, Inc.

InspireMD seeks to utilize its proprietary MGuard™ technology to make its products the industry standard for embolic protection stents and to provide a superior solution to the key clinical issues of current stenting in patients with a high risk of distal embolization, no reflow and major adverse cardiac events.

InspireMD intends to pursue applications of this technology in coronary, carotid and peripheral artery procedures.  InspireMD's common stock is quoted on the NYSE MKT under the ticker symbol NSPR.

MGuard™ EPS is CE Mark approved. It is not approved for sale in the U.S. by the FDA at this time.

Investor Contacts:
Todd Fromer / Garth Russell
KCSA Strategic Communications
Phone: 212-896-1215 / 212-896-1250
Email: tfromer@kcsa.com / grussell@kcsa.com

Media Contacts:
Lewis Goldberg / Samantha Wolf
KCSA Strategic Communications
Phone: 212-896-1216 / 212-896-1220
Email: lgoldberg@kcsa.com / swolf@kcsa.com


'/>"/>
SOURCE InspireMD
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. InspireMD Reports Fourth Quarter and Fiscal Year 2013 Results
2. InspireMD Appoints David Blossom as Vice President of Global Marketing and Strategy
3. InspireMD Announces Participation in Two Investor Conferences in September
4. InspireMD Completes First Phase of Manufacturing Upgrade and Partners with HealthLink for Global Logistics and Distribution Services
5. InspireMDs MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group
6. InspireMD Reports Financial Results For Period Ended March 31, 2013
7. InspireMD Receives Approval From US Food and Drug Administration to Begin US Regulatory Trial
8. InspireMD Closes $25 Million Underwritten Public Offering
9. InspireMD Announces Pricing of Underwritten Public Offering of Common Stock and Listing on NYSE MKT
10. InspireMD Receives CE Mark Approval for Carotid Embolic Protection Stent
11. InspireMD Files Amended Registration Statement for Proposed Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/13/2019)... ... June 13, 2019 , ... The American Psychiatric Nurses ... to succeed current executive director Nicholas Croce Jr., MS. The search will be led ... of Directors, past APNA Presidents, and Council and Chapter leaders. , The job description ...
(Date:6/13/2019)... ... , ... RxNT announced today that it has been named by ... RxNT is a leader in healthcare technology solutions. This is the fourth time RxNT ... highlight the best software products from North American small businesses. RxNT won the FrontRunner ...
(Date:6/13/2019)... ... 13, 2019 , ... HMP, a leading healthcare education and events company, today ... 25 Fastest-Growing Shows in Net Square Footage” by Trade Show News Network (TSNN). The ... over that period. Winners will be honored during the 2019 TSNN Awards, taking place ...
Breaking Medicine Technology:
(Date:6/13/2019)... ST. PETERSBURG, Fla. (PRWEB) , ... June 13, ... ... cultivation and research company today announced that it has signed a memorandum of ... ingredients (API) for its drug product MMJ-001 and MMJ-002. , MMJ BioPharma Cultivation ...
(Date:6/13/2019)... ... June 13, 2019 , ... Hard money lenders like Monroe ... and the funds can also be provided quickly. If the documentation and collateral are ... are able to avoid the federal oversight involved with a traditional lender, which allows ...
(Date:6/13/2019)... ... 13, 2019 , ... Many people with back pain that radiates down their ... is widely misunderstood and so are its treatments, according to Kaliq Chang, MD, double ... , “Sciatica is commonly used to describe nerve-like pain traveling down the legs, ...
(Date:6/13/2019)... ... June 13, 2019 , ... ... Inhibitors” presented at the American Diabetes Association (ADA) Scientific Sessions 2019 involving the ... treated with an SGLT-2 inhibitor. SGLT-2 inhibitors are used to lower glucose levels ...
(Date:6/12/2019)... NORWELL, Mass. (PRWEB) , ... June 12, 2019 , ... ... for a pilot program to offer telehealth and remote patient monitoring. Following its full-scale ... to over 120 patients a month. Since the beginning of 2019, NVNA has achieved ...
Breaking Medicine News(10 mins):